lactic acid has been researched along with linsidomine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hagino, Y; Matsui, S; Nomura, H; Nomura, T; Ohtsuki, M; Sumi-Ichinose, C | 1 |
Han, C; Lautt, WW; Ming, Z | 1 |
An, Z; Cherrington, AD; Dardevet, DP; DiCostanzo, CA; Edgerton, DS; Moore, MC; Neal, DW | 1 |
Cherrington, AD; Dicostanzo, CA; Farmer, B; Moore, MC; Neal, DW; Rodewald, TD; Smith, MS; Williams, PE | 1 |
4 other study(ies) available for lactic acid and linsidomine
Article | Year |
---|---|
Nitric oxide donor NOR 3 inhibits ketogenesis from oleate in isolated rat hepatocytes by a cyclic GMP-independent mechanism.
Topics: Adenosine Triphosphate; Animals; Benzoates; Calcium; Cells, Cultured; Cyclic GMP; Imidazoles; Lactic Acid; Liver; Male; Molsidomine; Nitric Oxide; Nitro Compounds; Oleic Acid; Penicillamine; Rats; Rats, Wistar; S-Nitroso-N-Acetylpenicillamine; Sodium Nitrite; Vasodilator Agents | 1998 |
Shear stress-induced nitric oxide antagonizes adenosine effects on intestinal metabolism.
Topics: Adenosine; Animals; Blood Flow Velocity; Cats; Drug Synergism; Enzyme Inhibitors; Female; Hemorheology; Intestine, Small; Lactic Acid; Male; Mesenteric Artery, Superior; Molsidomine; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Oxygen; Oxygen Consumption; Vasodilation | 1999 |
Effects of the nitric oxide donor SIN-1 on net hepatic glucose uptake in the conscious dog.
Topics: Animals; Blood Glucose; Blood Pressure; Carbon; Dogs; Fatty Acids, Nonesterified; Glucagon; Glucose; Glycerol; Heart Rate; Infusions, Intravenous; Insulin; Lactic Acid; Liver; Liver Circulation; Molsidomine; Nitric Oxide Donors; Portal Vein | 2008 |
Hepatic portal venous delivery of a nitric oxide synthase inhibitor enhances net hepatic glucose uptake.
Topics: Animals; Blood Glucose; Carbon; Catheterization; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fatty Acids, Nonesterified; Female; Glycerol; Hyperglycemia; Hyperinsulinism; Lactic Acid; Liver; Male; Molsidomine; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Portal Vein; Postprandial Period | 2008 |